Does GABAPENTIN Cause Agranulocytosis? 69 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Agranulocytosis have been filed in association with GABAPENTIN (Gabapentin). This represents 0.1% of all adverse event reports for GABAPENTIN.
69
Reports of Agranulocytosis with GABAPENTIN
0.1%
of all GABAPENTIN reports
7
Deaths
45
Hospitalizations
How Dangerous Is Agranulocytosis From GABAPENTIN?
Of the 69 reports, 7 (10.1%) resulted in death, 45 (65.2%) required hospitalization, and 23 (33.3%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does GABAPENTIN Cause?
Drug ineffective (10,914)
Drug hypersensitivity (6,833)
Off label use (6,729)
Drug ineffective for unapproved indication (5,231)
Product use in unapproved indication (4,919)
Toxicity to various agents (4,839)
Completed suicide (4,111)
Dizziness (4,107)
Somnolence (3,798)
Fatigue (3,791)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which GABAPENTIN Alternatives Have Lower Agranulocytosis Risk?
GABAPENTIN vs GABAPENTIN ENACARBIL
GABAPENTIN vs GADAVIST
GABAPENTIN vs GADOBENATE DIMEGLUMINE
GABAPENTIN vs GADOBUTROL
GABAPENTIN vs GADODIAMIDE